review article | Q7318358 |
scholarly article | Q13442814 |
P2093 | author name string | Rajendra Prasad | |
Manpreet K Rawal | |||
P2860 | cites work | A human-curated annotation of the Candida albicans genome | Q21145286 |
TCDB: the Transporter Classification Database for membrane transport protein analyses and information | Q24536325 | ||
The ATP binding cassette transporters Pdr5 and Snq2 of Saccharomyces cerevisiae can mediate transport of steroids in vivo | Q27931225 | ||
ATPase and multidrug transport activities of the overexpressed yeast ABC protein Yor1p | Q27936618 | ||
A major superfamily of transmembrane facilitators that catalyse uniport, symport and antiport | Q28266457 | ||
Molecular cloning and characterization of a novel gene of Candida albicans, CDR1, conferring multiple resistance to drugs and antifungals | Q28293585 | ||
Employing information theoretic measures and mutagenesis to identify residues critical for drug-proton antiport function in Mdr1p of Candida albicans | Q28474339 | ||
A mutation in intracellular loop 4 affects the drug-efflux activity of the yeast multidrug resistance ABC transporter Pdr5p | Q28478735 | ||
Epidemiology of invasive candidiasis: a persistent public health problem | Q29616758 | ||
Isolation and sequence analysis of the gene for translation elongation factor 3 from Candida albicans | Q31156776 | ||
A fourth gene from the Candida albicans CDR family of ABC transporters | Q32001895 | ||
Disruption studies of a Candida albicans gene, ELF1: a member of the ATP-binding cassette family | Q32032209 | ||
Genetic separation of FK506 susceptibility and drug transport in the yeast Pdr5 ATP-binding cassette multidrug resistance transporter. | Q32133639 | ||
MFS transportome of the human pathogenic yeast Candida albicans | Q33389525 | ||
The amino acid residues of transmembrane helix 5 of multidrug resistance protein CaCdr1p of Candida albicans are involved in substrate specificity and drug transport | Q33560121 | ||
Fungal PDR transporters: Phylogeny, topology, motifs and function. | Q33624643 | ||
Candida albicans gene encoding resistance to benomyl and methotrexate is a multidrug resistance gene | Q33752151 | ||
Chemical specificity of the PDR5 multidrug resistance gene product of Saccharomyces cerevisiae based on studies with tri-n-alkyltin chlorides | Q33978498 | ||
Divergent signature motifs of nucleotide binding domains of ABC multidrug transporter, CaCdr1p of pathogenic Candida albicans, are functionally asymmetric and noninterchangeable | Q34049370 | ||
Steroid binding protein(s) in yeasts | Q68944603 | ||
Ketoconazole binds to the intracellular corticosteroid-binding protein in Candida albicans | Q70183351 | ||
Efflux-mediated resistance to fluconazole could be modulated by sterol homeostasis in Saccharomyces cerevisiae | Q74138000 | ||
Expression of CDR1, a multidrug resistance gene of Candida albicans: transcriptional activation by heat shock, drugs and human steroid hormones | Q74416153 | ||
Identification of polymorphic mutant alleles of CaMDR1, a major facilitator of Candida albicans which confers multidrug resistance, and its in vitro transcriptional activation | Q77323771 | ||
Complete inventory of ABC proteins in human pathogenic yeast, Candida albicans | Q81411882 | ||
Alanine scanning of all cysteines and construction of a functional cysteine-less Cdr1p, a multidrug ABC transporter of Candida albicans | Q82937705 | ||
Chimeras of the ABC drug transporter Cdr1p reveal functional indispensability of transmembrane domains and nucleotide-binding domains, but transmembrane segment 12 is replaceable with the corresponding homologous region of the non-drug transporter C | Q83170269 | ||
Analysis of physico-chemical properties of substrates of ABC and MFS multidrug transporters of pathogenic Candida albicans | Q84804979 | ||
The signaling interface of the yeast multidrug transporter Pdr5 adopts a cis conformation, and there are functional overlap and equivalence of the deviant and canonical Q-loop residues | Q34196332 | ||
Intragenic Suppressing Mutations Correct the Folding and Intracellular Traffic of Misfolded Mutants of Yor1p, a Eukaryotic Drug Transporter | Q34298963 | ||
Specific interactions between the Candida albicans ABC transporter Cdr1p ectodomain and a D-octapeptide derivative inhibitor | Q34334444 | ||
The ATP switch model for ABC transporters | Q34353789 | ||
Cloning of Candida albicans genes conferring resistance to azole antifungal agents: characterization of CDR2, a new multidrug ABC transporter gene. | Q34417276 | ||
Drug resistance in yeasts--an emerging scenario | Q34695128 | ||
The central cytoplasmic loop of the major facilitator superfamily of transport proteins governs efficient membrane insertion | Q35191643 | ||
Functional characterization of Candida albicans ABC transporter Cdr1p. | Q35697281 | ||
Multidrug resistance in yeast Candida | Q35983675 | ||
Changing patterns and trends in systemic fungal infections | Q36239992 | ||
The transmission interface of the Saccharomyces cerevisiae multidrug transporter Pdr5: Val-656 located in intracellular loop 2 plays a major role in drug resistance. | Q36558351 | ||
Proton-dependent multidrug efflux systems | Q36672016 | ||
Conserved Asp327 of walker B motif in the N-terminal nucleotide binding domain (NBD-1) of Cdr1p of Candida albicans has acquired a new role in ATP hydrolysis | Q36853224 | ||
Sorting signals within the Saccharomyces cerevisiae sporulation-specific dityrosine transporter, Dtr1p, C terminus promote Golgi-to-prospore membrane transport | Q36939035 | ||
Mutations define cross-talk between the N-terminal nucleotide-binding domain and transmembrane helix-2 of the yeast multidrug transporter Pdr5: possible conservation of a signaling interface for coupling ATP hydrolysis to drug transport | Q37000251 | ||
Efflux-mediated antifungal drug resistance. | Q37156645 | ||
Current perspectives on echinocandin class drugs | Q37554055 | ||
The multidrug transporter Pdr5: a molecular diode? | Q37824859 | ||
Yeast ATP-binding cassette transporters conferring multidrug resistance | Q38019037 | ||
Purification and characterization of the N-terminal nucleotide binding domain of an ABC drug transporter of Candida albicans: uncommon cysteine 193 of Walker A is critical for ATP hydrolysis | Q38350658 | ||
The TetA(K) tetracycline/H(+) antiporter from Staphylococcus aureus: mutagenesis and functional analysis of motif C. | Q39499430 | ||
Functional role of the intracellular loop linking transmembrane domains 6 and 7 of the human dipeptide transporter hPEPT1 | Q39628283 | ||
The Candida albicans CDR3 gene codes for an opaque-phase ABC transporter | Q39848020 | ||
Functionally Relevant Residues of Cdr1p: A Multidrug ABC Transporter of Human Pathogenic Candida albicans | Q40720740 | ||
Specificity of drug transport mediated by CaMDR1: a major facilitator of Candida albicans | Q40778850 | ||
Cytoplasmic domains of the reduced folate carrier are essential for trafficking, but not function | Q41881973 | ||
Mapping of interdomain interfaces required for the functional architecture of Yor1p, a eukaryotic ATP-binding cassette (ABC) transporter | Q41917414 | ||
Insight into pleiotropic drug resistance ATP-binding cassette pump drug transport through mutagenesis of Cdr1p transmembrane domains. | Q42563449 | ||
Structure and function analysis of CaMdr1p, a major facilitator superfamily antifungal efflux transporter protein of Candida albicans: identification of amino acid residues critical for drug/H+ transport | Q42912738 | ||
A key structural domain of the Candida albicans Mdr1 protein. | Q43551296 | ||
The large cytoplasmic loop of the glucose transporter GLUT1 is an essential structural element for function | Q43840163 | ||
ABC transporters Cdr1p, Cdr2p and Cdr3p of a human pathogen Candida albicans are general phospholipid translocators | Q43900293 | ||
ABC multidrug transporter Cdr1p of Candida albicans has divergent nucleotide-binding domains which display functional asymmetry | Q45069193 | ||
Functional characterization of N-terminal nucleotide binding domain (NBD-1) of a major ABC drug transporter Cdr1p of Candida albicans: uncommon but conserved Trp326 of Walker B is important for ATP binding. | Q46454431 | ||
Alanine scanning of transmembrane helix 11 of Cdr1p ABC antifungal efflux pump of Candida albicans: identification of amino acid residues critical for drug efflux. | Q46529075 | ||
A novel catalytic mechanism for ATP hydrolysis employed by the N-terminal nucleotide-binding domain of Cdr1p, a multidrug ABC transporter of Candida albicans | Q46579767 | ||
Characterization of Cdr1p, a major multidrug efflux protein of Candida albicans: purified protein is amenable to intrinsic fluorescence analysis. | Q46942247 | ||
A Ste6p/P-glycoprotein homologue from the asexual yeast Candida albicans transports the a-factor mating pheromone in Saccharomyces cerevisiae | Q48039893 | ||
Functional analysis of a vacuolar ABC transporter in wild-type Candida albicans reveals its involvement in virulence | Q48310913 | ||
Characterisation of human steroid hormone transport mediated by Cdr1p, a multidrug transporter of Candida albicans, belonging to the ATP binding cassette super family. | Q52528972 | ||
Topology, structure and evolution of two families of proteins involved in antibiotic and antiseptic resistance in eukaryotes and prokaryotes--an analysis. | Q54247541 | ||
P304 | page(s) | 202 | |
P577 | publication date | 2014-08-29 | |
P1433 | published in | Frontiers in Pharmacology | Q2681208 |
P1476 | title | Efflux pump proteins in antifungal resistance | |
P478 | volume | 5 |
Q38821811 | Ambroxol Hydrochloride Combined with Fluconazole Reverses the Resistance of Candida albicans to Fluconazole |
Q36132766 | Anticandidal Effect and Mechanisms of Monoterpenoid, Perillyl Alcohol against Candida albicans |
Q92732704 | Antifungal Styryloquinolines as Candida albicans Efflux Pump Inhibitors: Styryloquinolines are ABC Transporter Inhibitors |
Q28818603 | Antifungal Therapy: New Advances in the Understanding and Treatment of Mycosis |
Q55378971 | Antifungal tolerance is a subpopulation effect distinct from resistance and is associated with persistent candidemia. |
Q58806129 | Biguanides enhance antifungal activity against Candida glabrata |
Q38684284 | Candida Efflux ATPases and Antiporters in Clinical Drug Resistance. |
Q90297410 | Candida Infections and Therapeutic Strategies: Mechanisms of Action for Traditional and Alternative Agents |
Q55154267 | Characterization of a promiscuous cadmium and arsenic resistance mechanism in Thermus thermophilus HB27 and potential application of a novel bioreporter system. |
Q38314467 | Clinical pharmacology of antifungal agents to overcome drug resistance in pediatric patients |
Q30248243 | Drug resistance in eukaryotic microorganisms |
Q48247736 | Effect of Efflux Transporter Inhibition on the Distribution of Fluconazole in the Rat Brain. |
Q36342657 | Enhancing Drug Efficacy and Therapeutic Index through Cheminformatics-Based Selection of Small Molecule Binary Weapons That Improve Transporter-Mediated Targeting: A Cytotoxicity System Based on Gemcitabine |
Q91692724 | Eucalyptal D Enhances the Antifungal Effect of Fluconazole on Fluconazole-Resistant Candida albicans by Competitively Inhibiting Efflux Pump |
Q58695993 | Fungicidal action of geraniol against Candida albicans is potentiated by abrogated CaCdr1p drug efflux and fluconazole synergism |
Q38837289 | How can we bolster the antifungal drug discovery pipeline? |
Q39335647 | Identification and functional characterization of Penicillium marneffei pleiotropic drug resistance transporters ABC1 and ABC2. |
Q61447566 | Influence of subinhibitory antifungal concentrations on extracellular hydrolases and biofilm production by Candida albicans recovered from Egyptian patients |
Q39201536 | Linear Epitopes of Paracoccidioides brasiliensis and Other Fungal Agents of Human Systemic Mycoses As Vaccine Candidates |
Q40166236 | Loss of C-5 Sterol Desaturase Activity Results in Increased Resistance to Azole and Echinocandin Antifungals in a Clinical Isolate of Candida parapsilosis. |
Q38724208 | Management of Candida biofilms: state of knowledge and new options for prevention and eradication |
Q42745431 | Newly identified motifs in Candida albicans Cdr1 protein nucleotide binding domains are pleiotropic drug resistance subfamily-specific and functionally asymmetric |
Q48137767 | NmeA, a novel efflux transporter specific for nucleobases and nucleosides, contributes to metal resistance in Aspergillus nidulans |
Q89976298 | Novel 2,4-Disubstituted-1,3-Thiazole Derivatives: Synthesis, Anti-Candida Activity Evaluation and Interaction with Bovine Serum Albumine |
Q91739554 | Ospemifene displays broad-spectrum synergistic interactions with itraconazole through potent interference with fungal efflux activities |
Q61809091 | Physical Interaction of Sodium Houttuyfonate With β-1,3-Glucan Evokes Cell Wall Remodeling |
Q40602135 | Prevalence and Fluconazole Susceptibility Profile of Candida spp. Clinical Isolates in a Brazilian Tertiary Hospital in Minas Gerais, Brazil |
Q92711755 | Proton pump inhibitors act synergistically with fluconazole against resistant Candida albicans |
Q94554889 | Repurposing approach identifies pitavastatin as a potent azole chemosensitizing agent effective against azole-resistant Candida species |
Q91899329 | Repurposing of Ribavirin as an Adjunct Therapy against Invasive Candida Strains in an In Vitro Study |
Q33851378 | Steroid-binding receptors in fungi: implication for systemic mycoses |
Q97883470 | Synergistic Effect of Berberine Hydrochloride and Fluconazole Against Candida albicans Resistant Isolates |
Q51279007 | Synergistic in vitro activity of sodium houttuyfonate with fluconazole against clinical Candida albicans strains under planktonic growing conditions. |
Q26786747 | The ABCs of Candida albicans Multidrug Transporter Cdr1 |
Q28550375 | The Candida albicans Histone Acetyltransferase Hat1 Regulates Stress Resistance and Virulence via Distinct Chromatin Assembly Pathways |
Q38334381 | The molecular mechanism of azole resistance in Aspergillus fumigatus: from bedside to bench and back. |
Q35804176 | The roles of CDR1, CDR2, and MDR1 in kaempferol-induced suppression with fluconazole-resistant Candida albicans |
Q27861953 | UDP-galactose and acetyl-CoA transporters as Plasmodium multidrug resistance genes |
Q90212129 | β-Lapachone enhances the antifungal activity of fluconazole against a Pdr5p-mediated resistant Saccharomyces cerevisiae strain |